WOK — Work Medical Technology Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Work Medical Technology, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 1.22 | 6.27 | 0.944 | 0.063 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 4.58 | 0.641 | 0.981 | 0.176 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 18.1 | -18.2 | -7.13 | 0.462 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | 27.2 | -7.18 | -2.26 | 2.21 |
| Capital Expenditures | -17.5 | -0.06 | -2.01 | -0.583 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 0.71 | 0 | 0.665 | — |
| Sale of Business | ||||
| Sale of Fixed Assets | ||||
| Cash from Investing Activities | -16.8 | -0.06 | -1.35 | -0.583 |
| Financing Cash Flow Items | — | — | — | -1.36 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -10.3 | 7.99 | 3.57 | -0.729 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.054 | 0.673 | -0.1 | 0.864 |